Jump to: navigation, search

Health Care Cost Per Capita (US$ Purchasing Power Parity per Capita) - International Comparison of Expenditure on Healthcare Using Purchasing Power Parity US$

Basic Facts

Stage of development

Implemented

Potential or current usage

Measuring NZ’s national expenditure on the health care system can be used to compare national expenditure with other developed economies.

Brief overview of the measure

General description

Purchasing Power Parity (PPP) US$ is a way of saying absolutely how much is spent on healthcare per person using a technique to equalise the purchasing power of local currencies.

Rationale for selection

Purchasing Power Parity (PPP) US$ is a way of saying absolutely how much is spent on healthcare per person using a technique to equalise the purchasing power of local currencies. This is a measure of the costs of the whole system not of differences in cost between DHB. It is a way of comparing national expenditure with other developed economies.

Type of measure

Structure

Domain(s) of quality

Efficiency

Application and interpretation of the measure

Stated intent of the measure

This indicator measures national expenditure per capita on the health care system.

Caveats - Considerations

This indicator needs to be read alongside other general population health and outcome measures.

Level of health care delivery/setting

Specifies the level of health care delivery/setting to which the measure most appropriately applies. (Use of the measure at other levels of health care delivery may be possible, although it is important to note that in these instances some variables for the measure may be subject to change.)

Target population

Not applicable

Stratification by vulnerable populations

Not applicable

Calculation of the measure

Output of calculation

Healthcare expenditure per capita

Numerator description

Health care expenditure in US$ PPP

Numerator exclusions

None

Denominator description

Population (not age adjusted)

Time period

1 year

Data source

OECD

Method of extraction

Describes the source of the required data, and any challenges identified For example, for practice level indicators this may be the practice management system. For peer review/professional development purposes, the data source may be the patient record, utilising manual searches. For indicators with a higher level of focus, aggregated data at organisational levels or national data warehouses may provide data.

Appraisal of the measure

Availability of evidence to support application of the measure

The measure has been developed or endorsed by an organization that promotes rigorous development and use of clinical performance measures (at an international, national, regional or local level).

Evidence of feasibility and reliability of implementation

Reliability - The measure has been demonstrated to be reliable (i.e. free from random error)., Interpretation - The measure allows unambiguous interpretation of better or worse performance., Data extraction - Data collection specifications for the measure are well defined., Data sources - Required data elements for the measure can be obtained from existing data sources., Availability of data - Required data elements for the measure can be gathered during routine practice activities, IT software - Existing IT software is sufficient for data collection., Validity - The measure has been demonstrated to be valid (i.e. it measures what it purports to).

Other items

Owner details

Reference number

1882

Date of entry to library

2012-07-30 17:46:33

Owner (Organisation name)

Health Quality and Safety Commission, Indicators project team

Owner (Email contact)

richard.hamblin@hqsc.govt.nz

Creator (Organisation name)

Health Quality and Safety Commission, Indicators project team

Creator (Email contact)

richard.hamblin@hqsc.govt.nz